2026 ASLMS 45th Annual Conference Recordings (Non-CME) - Beyond Human Insight: AI in the Age of Aesthetic Innovation

Dr. Lilit Garibyan is a board-certified, practicing dermatologist and Associate Professor of dermatology at Harvard Medical School and Physician-Scientist at Wellman Center for Photomedicine at Massachusetts General Hospital. She has expertise in cutting edge translational research in areas of device development, dermatology, cutaneous neurobiology, adipose tissue, and immunology. She has spent 20+ years at Harvard Medical School, where she has taught and trained students, residents and fellows in dermatology, laser and energy-based devices, and in problem-based innovation. Her research focuses on innovative biomedical translational discoveries aimed at identifying unmet medical needs and working with multidisciplinary teams to develop novel treatments for those needs. Dr. Garibyan is an inventor on >16 pending and granted patents, has published over 60 original, peer-reviewed publications and has obtained over $5.3 million grant funding from Department of Defense and NIH for her innovative research. She is the inventor of a platform cooling technology with various therapeutic applications that has led to three venture-backed, start-up companies. She is the scientific co-founder of two of those companies.

Dr. Garibyan is the co-founder and the Director of the “Magic Wand Initiative” and the “Virtual Magic Wand” programs, which teach the process of innovation to clinicians. These internationally-recognized programs empower, engage, and teach healthcare professionals on how to identify unmet needs and collaborate to identify and implement solutions to problems. Dr Garibyan has given many national and international lectures on the topic of engaging clinicians in problem-based innovation. She had directed sessions and led workshops in national and international meetings designed to engage healthcare workers in innovation.

Dr. Garibyan received her B.S. summa cum laude from University of California Los Angeles, her M.D. from Harvard Medical School, and her Ph.D. from Harvard University in Experimental Pathology/Immunology.

Kerrie Jiang, RN, MSN

Kerrie Jiang is a product development specialist with over two decades of experience leading the development and commercialization of cutting-edge medical aesthetic devices. She has successfully lauched more than 20 products to global markets, including EU, China, Korea and Japan. She takes pride in working with multiple first-in-class technologies from novel concept to global commercial success, covering energy sources from the first non-ablative and ablative fractional lasers, radiofrequency, cryolipolysis, electromagnetic stimulation, to high-intensity focused ultrasound. Additionally, her career spans leadership roles at industry giants such as Allergan and Merz, where she led multi-functional teams across engineering, clinical affairs, regulatory strategy and medical affairs. From start-ups to multi-national corporations, she is keenly aware of the various organizational strengths that can accelerate product development.
Currently, Kerrie partners with early-stage startups to build products that are clinically meaningful, commercially viable, and regulatory-ready from day one. She specializes in aligning product development with market needs, accelerating clinical validation, and crafting regulatory strategies that enable speed-to-market in highly regulated environments. Her passion lies in solving real life challenges through innovative, evidence-backed technologies that empower both practitioners and patients.

Arlene Ruiz de Luzuriaga is an Associate Professor of Medicine in the Section of Dermatology, Co-director of the Pigmented Lesion Clinic, and Vice-Chief for Dermatopathology Operations at the University of Chicago. Her clinical focus is on total body photography, dermoscopy, skin cancer surveillance, and melanoma prevention and early detection. She is interested in use of technology for the improvement of patient care, diagnosis and treatment algorithms, quality improvement, and medical education.
Through her role as the Director of Innovation and Digital Technology for the Bucksbaum-Siegler Institute for Clinical Excellence at the University of Chicago, she seeks to support initiatives and research that examine how the patient-doctor relationship is affected by the implementation of digital health technology and artificial intelligence, and how this can serve to guide the development and incorporation of such innovations in healthcare.

Dr Diala Haykal is a Cosmetic and Laser Doctor, running her own specialized clinic and training center, Centre Médical Laser Esthétique Palaiseau, in France, offering patients a wide range of modern cosmetic treatments. She holds a diploma in Aesthetic Medicine and Lasers from Paris V Descartes University. Additionally, she holds an American Board diploma in Aesthetic Medicine from the American Academy of Aesthetic Medicine, where she is also a trainer and expert in the American Academy of Continuous Education. She has also completed Leadership in HealthCare programs at HEC Business School, as well as at Harvard University and Cambridge Judge Business School. Furthermore, she has pursued studies in Artificial Intelligence in HealthCare at both Harvard University and MIT Sloan Management School.
In addition to her academic achievements, Dr. Haykal serves as a tutor and supervisor at Paris-Sorbonne University. Alongside her numerous achievements, she has made significant contributions through her international publications in cosmetic dermatology and lasers. She is also a reviewer for esteemed journals in her domain and serves as an editor for several scientific journals. Her expertise extends beyond academia as she acts as an international speaker and KOL for various industries. Dr. Haykal is an esteemed member of the American Board of Aesthetic Medicine and actively participates in professional societies such as the French Society of Lasers in Dermatology, the European Society for Lasers and Energy-Based Devices, and the French Society of Cosmetic Medicine. She is also a member of the European AI Alliance, showcasing her involvement in the field of artificial intelligence within the healthcare domain.

Dr. Shlomit Halachmi studied chemical engineering and biology at MIT, after which she studied medicine and molecular biology at Harvard Medical School, and completed her dermatology training at the combined Boston University/Tufts University residency program.  In addition to her clinical dermatology experience, which focuses on lasers and other energy-based devices, she has worked in senior positions in drug and medical device development as well as at the FDA.